Zydus Wellness acquires UK-based Comfort Click

IMT News Desk
IMT News Desk
· 2 min read

Forays into the UK and EU markets

Zydus Wellness announced that Alidac UK, a wholly owned subsidiary, has signed a definitive agreement to acquire UK-based Comfort Click, including its three subsidiaries located in Ireland, the US, and India. The acquisition marks Zydus Wellness’ first overseas acquisition and its entry into the Vitamins, Minerals, and Supplements (VMS) segment. The target company, operating in the UK and major markets of Europe, posted revenues of GBP 134 million (unaudited) for the financial year ended on June 30, 2025, with a five-year CAGR of 57 per cent, and recorded an adjusted operating profit of GBP 21 million. The VMS market in Europe is estimated to be around £11 billion.

The equity value is GBP 239 million, subject to customary and agreed adjustments under the terms of the SPA.

Dr Sharvil Patel, Chairman, Zydus Wellness, “The global acquisition of Comfort Click, a leading player in the digital vitamins, minerals and supplements space, marks a significant step in our journey to empower consumers to make informed choices and embrace wellness-focused products as part of their path to better health. This strategic move reflects our aspiration to be a forward-looking company that not only anticipates consumer needs but also enables easy access to them. With Comfort Click, we are strengthening our global capabilities, deepening our presence in digital health and personalised wellness, and exploring scalable and sustainable models that will shape the future of wellbeing. We are excited and exploring new possibilities driven by innovation and a customer-first approach.”

Tarun Arora, CEO and Whole-Time Director, Zydus Wellness, said “The acquisition of Comfort Click is a significant step forward in our journey to strengthen our leadership in the wellness space. It aligns with our strategic vision of expanding Zydus Wellness’ international footprint while deepening our capabilities in consumer-centric health and wellbeing solutions. Comfort Click brings a strong portfolio, a digital-first approach, and a shared commitment to innovation and quality. We are excited to welcome the employees, consumers, partners, and stakeholders as we work together to unlock new opportunities and advance the wellness quotient worldwide.”

Read Next

Agenus announces closing of $141 M strategic collaboration with Zydus Lifesciences
Global News
January 20, 2026

Agenus announces closing of $141 M strategic collaboration with Zydus Lifesciences

To advance BOT+BAL and strengthen US manufacturing readiness Agenus, a leader in immuno-oncology innovation, announced the closing of its previously disclosed strategic collaboration with Zydus Lifesciences Ltd. The agreement is designed to accelerate global development and potential commercialisation of Agenus’ botensilimab and balstilimab (BOT+BAL) immunotherapy combination programme. The collaboration provides Agenus with strategic capital and […]
Article by: IMT News Desk
Venus Remedies secures marketing authorisation for Ceftazidime + Avibactam in Indonesia
Global News
January 16, 2026

Venus Remedies secures marketing authorisation for Ceftazidime + Avibactam in Indonesia

Approval marks Venus Remedies’ first anti-infective marketing authorisation in Indonesia and enables the country’s first generic entry for this critical antibiotic combination Venus Remedies has secured the marketing authorisation from the Indonesian regulatory authority for its combination antibiotic, Ceftazidime + Avibactam. This approval represents Venus Remedies’ first marketing authorization in the anti-infective segment in Indonesia […]
Article by: IMT News Desk
Wegovy pill approved in the US for weight management
Global News
December 26, 2025

Wegovy pill approved in the US for weight management

Novo Nordisk expects to launch the Wegovy pill in the US in early January 2026 Novo Nordisk announced that the US Food and Drug Administration (FDA) has approved the Wegovy pill (once-daily oral semaglutide 25 mg) to reduce excess body weight and maintain weight reduction long term and to reduce the risk of major adverse […]
Article by: IMT News Desk
Samsung Biologics America in agreement to acquire 100 per cent of Human Genome Sciences from GSK
Global News
December 24, 2025

Samsung Biologics America in agreement to acquire 100 per cent of Human Genome Sciences from GSK

Under the terms of the agreement, with closing anticipated toward the end of Q1 of 2026, Samsung Biologics will acquire the Rockville assets for $280 million Samsung Biologics, a leading contract development and manufacturing organization (CDMO), announced that its wholly owned US subsidiary, Samsung Biologics America, has entered into a definitive agreement to acquire 100 […]
Article by: IMT News Desk